News & Updates
Filter by Specialty:

Long-term statin users at risk of colon cancer
Use of statins does not appear to be chemopreventive against colorectal cancer (CRC), and no significant association exists between total cholesterol level and CRC risk, a study has found. In addition, long-term statin use may increase the risk of colon cancer.
Long-term statin users at risk of colon cancer
13 Jan 2022
Can digital health revolutionize IBD management?
Digital health technologies (DHTs) can help lower healthcare utilization and costs but appear to have not enough juice to reduce the risk of relapse, improve quality of life (QoL), and increase treatment adherence in patients with inflammatory bowel disease (IBD), according to a study.
Can digital health revolutionize IBD management?
13 Jan 2022
GI symptoms in COVID-19 more prevalent than previously reported
There appears to be a higher prevalence of gastrointestinal (GI) symptoms in hospitalized patients with COVID-19 than previously reported, reveals a recent study.
GI symptoms in COVID-19 more prevalent than previously reported
13 Jan 2022
Breakthrough infections with COVID-19 Delta variant linked to lower memory B cell response
The memory B cell response appears to be weaker in vaccinated individuals who develop breakthrough infections with the Delta variant of the coronavirus disease 2019 (COVID-19), according to a new Singapore study.
Breakthrough infections with COVID-19 Delta variant linked to lower memory B cell response
13 Jan 2022
Smokers more likely to develop COVID-19 complications
Among patients with COVID-19 infection, those who smoke are at higher risk of developing complications compared with those who do not smoke, according to a study from Malaysia.
Smokers more likely to develop COVID-19 complications
13 Jan 2022
Fulvestrant-palbociclib combo pre-progression improves PFS in ESR1+ mBC
Switching to a fulvestrant-palbociclib regimen prior to disease progression after detection of elevated ESR1 mutations in the blood of patients with hormone receptor-positive (HR+), HER2-negative (HER2-) metastatic breast cancer (mBC) who were receiving aromatase inhibitors (AIs) plus palbociclib extended their progression-free survival (PFS), results of the phase III PADA-1 trial showed.
Fulvestrant-palbociclib combo pre-progression improves PFS in ESR1+ mBC
12 Jan 2022
More than 1 in 4 young adults test seropositive for COVID-19
A recent study has shown that more than a quarter of young adults are seropositive for SARS-CoV-2, many of whom show single positivity with IgM. Such seropositivity was higher among those who had cases of the coronavirus disease 2019 (COVID-19) in the household and those who used public transport.